Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jcph.1822 http://scihub22266oqcxt.onion/10.1002/jcph.1822 33511638!8014753!33511638     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Pharmacol 2021 ; 61 (4): 429-460 Nephropedia Template TP {{tp|p=33511638|t=2021. Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review |pdf=|usr=}}{{33511638}} gab.com Text Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review JO: J Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33511638 #FOAvip Since the early days of 2020, the severe acute respiratory syndrome coronavirus 2 pandemic has become a global health concern. Currently, some therapies and vaccines have received US Food and Drug Administration approval or emergency use authorization for the management of coronavirus disease 2019. According to the pathophysiology of the disease, several medications have been evaluated in different clinical conditions of the disease. Evidence-based reviewing and categorizing these medications can guide the clinicians to select the proper medications according to each patient's condition. Therefore, we performed this review to categorize the coronavirus disease 2019 potential therapeutics and vaccines. Twit Text FOAVip Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review ????J Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33511638 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33511638 #FOAvip English Wikipedia <ref>{{Cite pmid|33511638}}</ref> Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review #MMPMID33511638 Khani E; Khiali S; Entezari-Maleki T J Clin Pharmacol 2021[Apr]; 61 (4): 429-460 PMID33511638show ga Since the early days of 2020, the severe acute respiratory syndrome coronavirus 2 pandemic has become a global health concern. Currently, some therapies and vaccines have received US Food and Drug Administration approval or emergency use authorization for the management of coronavirus disease 2019. According to the pathophysiology of the disease, several medications have been evaluated in different clinical conditions of the disease. Evidence-based reviewing and categorizing these medications can guide the clinicians to select the proper medications according to each patient's condition. Therefore, we performed this review to categorize the coronavirus disease 2019 potential therapeutics and vaccines. |*COVID-19 Drug Treatment[MESH] |Anti-Inflammatory Agents/pharmacology/*therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/pharmacology/*therapeutic use[MESH] |Antibodies, Neutralizing/pharmacology/therapeutic use[MESH] |Antiviral Agents/pharmacology/*therapeutic use[MESH] |COVID-19 Vaccines/pharmacology/*therapeutic use[MESH] |COVID-19/immunology/*prevention & control[MESH] |Evidence-Based Medicine[MESH] |Humans[MESH] |Practice Guidelines as Topic/standards[MESH]Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based (epmc).pdf DeepDyve Pubget Overpricing